Abstract
Visceral leishmaniasis (VL) may be fatal if not treated and, although hypergammaglobulinemia is a hallmark of VL, the contribution of antibodies in progression of disease remains unknown. Effector and regulatory functions of antibodies rely on their interactions with type I and II Fc receptors and these interactions are tuned by the patterns of antibody Fc N-glycosylation. We recently sho…